In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Lung cancer is the leading cancer killer in both men and women; according to the American Cancer Society, more than 213,380 will be diagnosed in 2007 and more than 160,390 will die from the disease. Non-small cell is the most common type of the disease, accounting for about 80 percent of all lung cancers, says Charles Lu, M.D., associate professor in M. D. Anderson's Department of Thoracic/Head and Neck Medical Oncology.